|
|
||||||||
Cooperative Research Centre for Oral Health Science, School of Dental Science, The University of Melbourne, 720 Swanston Street, Victoria, 3010, Australia
Correspondence
Eric C. Reynolds
e.reynolds{at}unimelb.edu.au
| ABSTRACT |
|---|
|
|
|---|
-p-tosyl-lysine chloromethlyketone; wt, wild-type; z-L-Lys-pNA, benzyloxycarbonyl-L-Lys-p-nitroanilide| INTRODUCTION |
|---|
|
|
|---|
Colonization of the subgingival crevice by a consortium of Gram-negative bacteria with the development of a biofilm has been strongly associated with the onset and progression of chronic periodontitis (Socransky & Haffajee, 2000
). Three bacterial species within the biofilm have been strongly associated with chronic periodontitis: Porphyromonas gingivalis, Bacteroides forsythus and Treponema denticola (Socransky et al., 1998
). Among these bacteria, P. gingivalis has received considerable attention as it has been more closely associated with disease severity (Socransky et al., 1998
). Furthermore, P. gingivalis has been shown to represent up to 50 % of the anaerobically cultivatable subgingival bacteria from active disease sites (Slots, 1982
) and is rarely cultured from subjects without periodontitis (van Winkelhoff et al., 2002
). Furthermore, in animal models, subgingival implantation of P. gingivalis in mice (Baker et al., 1994
), primates (Persson et al., 1994
) and rats (Evans et al., 1992
; Rajapakse et al., 2002
) induces periodontal bone loss.
P. gingivalis has a number of putative virulence factors that contribute to its pathogenicity. Among them, the Arg- and Lys-specific cysteine proteinases, designated RgpA and Kgp, respectively, are considered major virulence factors as they have been suggested to play a key role in disease pathogenesis (reviewed by O'Brien-Simpson et al., 2003
). RgpA and Kgp are encoded by two genes, namely rgpA and kgp (Curtis et al., 1999
). The rgpA gene encodes a polyprotein consisting of an N-terminal preprofragment followed by a 45 kDa Arg-specific, calcium-stabilized cysteine proteinase, RgpAcat, and four sequence-related adhesin domains: RgpAA1, RgpAA2, RgpAA3 and RgpAA4 (O'Brien-Simpson et al., 2003
). Similarly, the kgp gene encodes a polyprotein with a N-terminal preprofragment followed by a 48 kDa Lys-specific cysteine proteinase, Kgpcat, and five C-terminal adhesin domains: KgpA1, KgpA2, KgpA3, KgpA4 and KgpA5 (O'Brien-Simpson et al., 2003
). Although the proteolytic domains of rgpA and kgp are divergent, with only 25 % identity, their C-terminal adhesin domains share high sequence similarities (Slakeski et al., 1998
). In fact, the A2 adhesins RgpAA2 and KgpA2 are identical in both gene products (Slakeski et al., 1999
).
Depending on the P. gingivalis strain, age of culture and purification method, several forms of RgpA and Kgp, both cell-associated and soluble, have been purified and characterized (reviewed by Potempa et al., 2003
). The Arg- and Lys-specific proteinases have been purified as monomeric proteins (Bedi & Williams, 1994
; Chen et al., 1992
) and as multimeric complexes where the proteinase domains are non-covalently associated with a number of adhesin/haemagglutinin domains (Bhogal et al., 1997
; Pike et al., 1994
). Using sonication of exponentially growing P. gingivalis W50 cells and three chromatographic procedures, Bhogal et al. (1997)
purified and characterized the major cell-associated Arg- and Lys-specific proteinases as a 300 kDa protein complex containing the Arg and Lys proteinases and their associated adhesins. It was proposed that, after the proteolytic processing of the RgpA and Kgp polyproteins into individual domains, they aggregate via adhesin-binding motifs (ABMs) to form the non-covalently associated cell-surface complex designated the RgpA-Kgp proteinaseadhesin complex (Bhogal et al., 1997
; Slakeski et al., 1998
). Recently, Takii et al. (2005)
, using sucrose monolaurate to extract P. gingivalis cells, confirmed the presence of this proteinaseadhesin complex and its component proteins from RgpA and Kgp, identified by Bhogal et al. (1997)
, but suggested that it existed as larger aggregates (660 kDa) in the form of 10 nm diameter particles on the cell surface. However, Takii et al. (2005)
used antibodies to recombinant RgpA domains to identify the subunits of the complex and not mass spectrometry. The high sequence similarly of the adhesin domains requires a mass spectrometric approach for definitive identification. Soluble forms of the Arg- and Lys-specific proteinases complexed with adhesin domains have been purified and characterized from culture supernatants, mainly from P. gingivalis strain HG66, which reportedly secretes the entire rgpA and kgp gene products into the culture media (reviewed by Potempa et al., 2003
).
The RgpA and Kgp proteinases and their associated adhesins are recognized as major virulence factors for P. gingivalis and therefore are of major interest to study in a purified form (Lamont & Jenkinson, 2000
; O'Brien-Simpson et al., 2003
). However, the reported methodologies for extracting and purifying RgpA and Kgp as complexes from the cell involve a range of extraction methods and three or more chromatographic purification steps, with many of the purified products being poorly defined. Thus, the major objective of this study was to develop a simple and effective procedure for the extraction and purification of the RgpA and Kgp proteinaseadhesin complexes from P. gingivalis cells using Triton X-114 and then to comprehensively characterize the complexes for their subunits using mass spectrometry, as vaccines in an animal model and for their binding properties to a range of host proteins. The non-ionic detergent Triton X-114 was used to extract the complexes as it is a mild detergent that solubilizes membrane-associated proteins while retaining native protein structure (Bordier, 1981
) and has been used effectively to extract outer-membrane proteins from a range of bacteria (Brooks et al., 2006
; Cullen et al., 2002
; Radolf et al., 1988
).
| METHODS |
|---|
|
|
|---|
Extraction of the proteinaseadhesin complexes.
P. gingivalis strains W50 wild-type, W501 and KIA were grown to late exponential phase (in 2 l cultures), harvested by centrifugation (7500 g, 30 min, 4 °C) and washed twice with PG buffer (50 mM Tris/HCl, 150 mM NaCl, 5 mM CaCl2 and 5 mM cysteine-HCl, pH 8.0) in the anaerobic workstation. Cells were either (1) resuspended in PG buffer, total volume 30 ml, containing 0.5 % (v/v) Triton X114 and gently mixed at room temperature for 45 min (Triton complex) or (2) resuspended in 30 ml PG buffer and subjected to mild sonication using a Branson sonifier 250 with an output control of 3 and a 50 % duty cycle (sonication complex). The cell extract was centrifuged (7500 g, 30 min, 4 °C) and the collected supernatant centrifuged (40 000 g, 30 min, 4 °C). The supernatant was then filtered (0.2 µm) and the complexes were purified by arginine (Arg)-affinity chromatography. FPLC was performed at room temperature at a flow rate of 1.0 ml min1. The P. gingivalis extracts were applied to an Arg-Sepharose column (Hiload XK 16/10 Q, Pharmacia), installed in a Pharmacia GP-250 FPLC system, in TC 50 buffer (buffer A) (50 mM Tris/HCl, 50 mM NaCl, 5 mM CaCl2, pH 7.4) at a flow rate of 1 ml min1. Non-specifically bound proteins were eluted with a linear gradient of 040 % TC 50 buffer containing, 500 mM NaCl, 50 mM Tris/HCl, 5 mM CaCl2, pH 7.4 (buffer B) at a flow rate of 1.0 ml min1. The column was reequilibrated with buffer A and bound proteins eluted with TC 50 buffer containing 500 mM arginine, pH 7.4 at a flow rate of 1 ml min1. The eluate was monitored at 280 nm. All fractions were collected at 4 °C and stored at 70 °C before further processing.
Arginine-eluted FPLC fractions were concentrated using Vivaspin 20 concentrators (Vivascience) by centrifugation at 3000 g for 15 min periods at 4 °C until the eluate was reduced to a volume of approximately 1 ml. The filter membrane of the Vivaspin 20 concentrator was then rinsed with 1 ml TC 50 buffer. Concentrated fractions were then desalted using a PD-10 column (Amersham Pharmacia Biotech), equilibrated with TC 50 buffer and the proteins were eluted with the same buffer as per the manufacturer's instructions.
Arg-specific and Lys-specific proteinase assays.
Benzoyl-L-arg-p-nitroanilide (bz-L-arg-pna) (sigma) and benzyloxycarbonyl-L-lys-p-nitroanilide (z-L-Lys-pNA) (Novabiochem) were used to assay FPLC fractions for Arg- and Lys-specific proteolytic activity, respectively. Samples of each chromatographic fraction were diluted in TC 50 buffer (total volume 360 µl) and incubated for 10 min at 37 °C with 40 µl 100 mM cysteine, pH 8. After incubation, 400 µl of either Bz-L-arg-pna or z-L-lys-pna substrate (2 mm bz-L-arg-pna or 2 mm z-L-Lys-pNA) dissolved in 3 ml propan-2-ol and mixed with 7 ml enzyme buffer (400 mM Tris/HCl, 100 mM NaCl and 20 mM cysteine, pH 8) was added. The proteolytic activity was determined by measuring the absorbance at 410 nm for 3 min at 10 s intervals using a diode array spectrophotometer model 8452A (Hewlett Packard).
Size-exclusion chromatography.
This was performed using a macrosphere GPC 300Å column (7 µm, 250x4.6 mm, with exclusion limits of 75001 200 000 Da; Alltech) installed in a Waters Delta 600 HPLC system. Chromatography was performed at a flow rate of 0.5 ml min1 in 0.05 M KH2PO4 containing 0.15 M Na2SO4 (pH 7.0). Material eluted from the column was detected by determining absorbance at 280 nm. A standard curve of molecular mass gel filtration standards (Amersham Pharmacia Biotech) was used to determine the molecular mass of the eluted fractions.
SDS-PAGE.
SDS-PAGE was performed on FPLC fractions by using a Novex electrophoresis system with Novex 12 % (w/v) Tris/glycine precast mini gels (Invitrogen). Protein samples (10 or 30 µg) were precipitated by addition of trichloroacetic acid (TCA) to a final concentration of 10 % (v/v) and incubated 20 min at 4 °C. Precipitated proteins were collected by centrifugation (10 min, 16 000 g), resuspended in 20 µl reducing sample buffer [10 % (w/v) SDS, 0.05 % (w/v) bromophenol blue, 25 % (v/v) glycerol and 0.05 % (v/v) 2-mercaptoethanol] and the pH adjusted with the addition of 10 µl of 1.5 M Tris/HCl, pH 8.0, and then heated for 5 min at 100 °C. Samples were loaded onto the precast gels and electrophoresis was performed using a current of 3050 mA and a potential difference of 125 V. After completion of electrophoresis, the gels were fixed in destain [45 % (v/v) methanol, 10 % (v/v) acetic acid] for 3 min at room temperature. For Coomassie blue staining, gels were placed in Coomassie brilliant blue (CBB) [0.1 % (w/v) CBB R-250, 15 % (v/v) ethanol, 2.5 % (v/v) acetic acid], heated in a microwave until boiling and then allowed to cool for 5 min. The stain was removed and destain was added and heated in a microwave until boiling and allowed to cool for 5 min. Protein bands were visualized by rinsing gels in Milli Q water overnight.
N-terminal sequence analysis.
For sequence analysis, proteins were transferred onto a PVDF membrane (Problott, Applied Biosystems) using a transblot cell (Bio-Rad). The PVDF membrane was wetted in 100 % methanol and soaked in transfer buffer [10 mM CAPS, 10 % (v/v) methanol, pH 11.5] for 1 min. Transfer was performed using a potential difference of 60 V for 90 min. Membranes were stained with CBB for 30 s and destained in 50 % (v/v) aqueous methanol. Protein bands were excised and N-terminal sequences determined using a Hewlett Packard 10005A protein sequencer as previously described (Bhogal et al., 1997
).
In-gel digestion of proteins separated by SDS-PAGE and peptide mass fingerprinting.
CBB-stained protein bands from SDS-PAGE were excised and subjected to in-gel trypsin digestion and subsequent peptide extraction. Protein bands were excised from the CBB-stained SDS-PAGE gel and gel pieces were washed in 50 mM NH4HCO3/ethanol 1 : 1 (v/v), reduced and alkylated with DTT and iodoacetamide, respectively, and digested with sequencing-grade modified trypsin (10 ng µl1) (Promega) overnight at 37 °C as previously published (Mortz et al., 1994
). The peptide extract containing 25 mM NH4HCO3 was then analysed by mass spectrometry using an Ultraflex TOF/TOF instrument (Bruker Daltonics) in positive ion and reflectron mode. A saturated solution of 4-hydroxy-
-cyanocinnamic acid was prepared in 97 : 3 (v/v) acetone/0.1 % aqueous trifluoroacetic acid (TFA). A thin layer was prepared by pipetting and immediately removing 2 µl of this solution onto the 600 µm anchorchips of the target plate. Sample (0.5 µl) was deposited on the thin layers with 2.5 µl of 0.1 % (v/v) TFA, and allowed to adsorb for 5 min, after which the sample solution was removed, and the thin layers washed once with 10 µl ice-cold 0.1 % (v/v) TFA for 1 min. Spectra were calibrated by close external calibration using a standard peptide mix (Bruker Daltonics). MS/MS spectra were acquired using the Lift technique (Suckau et al., 2003
). Proteins were identified by peptide mass fingerprinting (PMF) and MS/MS ions searches against the P. gingivalis database (available from http://www.tigr.org) using an in-house Mascot search engine (Matrix Science).
Immunization and mouse lesion model.
The mouse lesion model protocols were approved by the University of Melbourne Ethics Committee for Animal Experimentation. BALB/c mice 68 weeks old (10 mice per group) were immunized subcutaneously (s.c., 100 µl) with 25 µg complex in phosphate-buffered saline (PBS, pH 7.4) emulsified in incomplete Freund's adjuvant (IFA). After 30 days, mice were boosted with 25 µg antigen (s.c., 100 µl, emulsified in IFA) and then 12 days later bled from the retrobulbar plexus. Two days after bleeding, mice were challenged with 7.5x109 viable cells of P. gingivalis strain ATCC 33277 by s.c. injection (100 µl) in the abdomen, and lesion development measured over 14 days. The P. gingivalis inocula were prepared in PG buffer in the anaerobic workstation as described above. The number of viable cells in the inocula was verified by enumeration on horse blood agar plates. Lesion sizes were statistically analysed using the KruskalWallis test and the MannWhitney U-Wilcoxon rank sum test with a Bonferroni correction for type 1 error. Effect sizes, represented as Cohen's d, were calculated using the effect size calculator provided on-line by Evidence-Based Education UK web site at http://www.cemcentre.org/. According to Cohen (1969)
a small effect size is 0.2
d<0.05, moderate 0.5
d<0.8 and large d
0.8.
ELISA.
ELISAs were performed in triplicate in wells of flat-bottom polyvinyl microtitre plates (Dynatech Laboratories) coated with 10 µg ml1 Triton-wt complex or sonication-wt complex in PBS, pH 7.4, overnight at 4 °C. After removal of the coating solution, 2 % (w/v) skim milk powder in PBS, pH 7.4, containing 0.1 % (v/v) Tween 20 was added to wells to block the uncoated plastic for 1 h at room temperature. After washing four times with washing buffer [PBS containing 0.1 % (v/v) Tween 20, pH 7.4 or (PBST)], serial dilutions of mouse sera in PBST containing 0.5 % (w/v) skim milk (SK-PBST) were added to each well and incubated for 16 h at room temperature. After washing six times with PBST, a 1/2000 dilution of goat antisera to mouse IgM, IgA, IgG1, IgG2a, IgG2b, or IgG3 (Sigma) was added in SK-PBST and allowed to bind for 2 h at room temperature. Plates were washed six times in PBST and a 1/5000 dilution of horseradish peroxidase-conjugated rabbit anti-goat immunoglobulin (Sigma) in SK-PBST was added to each well and incubated for 1 h at room temperature. After washing (six times, PBST), bound antibody was detected by the addition of 100 µl ABTS substrate [0.9 mM 2,2'-azino-bis (3-ethylbenz-thiazoline-6) sulfonic acid in 80 mM citric acid containing 0.005 % (v/v) hydrogen peroxide, pH 4.0] to each well. The A415 was measured using a Bio-Rad microplate reader model 450.
Western blot analysis using mouse protective sera.
Triton-wt complex and sonication-wt complex (15 µg) were subjected to SDS-PAGE and electrophoretically transferred onto a PVDF membrane as described above. The PVDF membrane was blocked with skim milk powder in TN buffer (50 mM Tris/HCl, 100 mM NaCl, pH 7.4) for 2 h at room temperature. The membrane was then incubated with anti-wt complex sera at a dilution of 1/25 in TN buffer, overnight at room temperature. After the incubation, the membrane was washed four times in TN buffer containing 0.05 % (v/v) Tween 20 and incubated with a 1/200 dilution of rabbit anti-mouse horseradish peroxidase-conjugated IgG (Sigma) for 2 h at room temperature. The membrane was washed four times with TN buffer containing 0.05 % (v/v) Tween 20 and the bound antibodies were detected by 0.005 % (w/v) 4-chloro-1-naphthol in TN buffer containing 16.6 % (v/v) methanol and 0.015 % (v/v) hydrogen peroxide (30 % solution).
Analysis of wt complex, RgpA complex and Kgp complex binding to host proteins.
Prior to the ELISA, the proteolytic activity of each proteinaseadhesin complex was inhibited by incubation with 5 mM N
-p-tosyl-lysine chloromethlyketone (TLCK; Sigma) for 30 min at room temperature. Excess TLCK was removed by using a PD-10 column equilibrated with TC 50 buffer with the proteins eluted according to the manufacturer's instructions in the same buffer (Amersham Pharmacia Biotech). ELISAs were performed in triplicate using a solution of 5 µg ml1 of either fibrinogen, fibronectin, collagen type V, laminin or haemoglobin in PBS, pH 7.4, to coat wells of flat-bottomed polyvinyl microtitre plates (Microtitre, Dynatech Laboratories) overnight at room temperature. After removing the coating solution, remaining uncoated plastic was blocked with 2 % (w/v) skim milk powder in PBST for 1 h at room temperature. After washing (4xPBST), equimolar amounts of TLCK-treated Triton-wt complex, sonication-wt complex, RgpA complex or Kgp complex in SK-PBST were added to the wells and incubated at room temperature for 2 h. After washing (6xPBST) a 1/5000 dilution of anti-complex sera in SK-PBST was added to each well and incubated 2 h at room temperature. After washing (6xPBST), bound antibody was detected by incubation with a 1/5000 dilution of horseradish peroxidase-conjugated anti-mouse immunoglobulin developed in goat (Sigma) in SK-PBST for 1 h at room temperature. Wells were then washed (6xPBST) and the plates were developed as described above.
ELISA results were used to derive the dissociation equilibrium constant (KD) based on an analogue of the MichaelisMenten equation (Qiu et al., 1996
): A=Amax[protein]/KD+[protein], where A is the absorbance at a given protein concentration, Amax is the maximum absorbance for the ELISA plate reader, [protein] is the protein concentration of the analyte and KD is the dissociation equilibrium constant for a given absorbance at a given protein concentration (ELISA data point). KD was calculated by a Scatchard analysis of 1/[protein] vs 1/KD (ELISA data point): 1/KD=m(1/c), where m is the slope of the line and c is the intercept at the y axis, with an R2 value >0.99.
| RESULTS |
|---|
|
|
|---|
threefold) Arg and Lys proteolytic activity compared with the sonication extract (Table 1
|
|
|
|
|
The Arg- and Lys-specific proteinase activities of the purified RgpA complex and Kgp complex were measured. The RgpA complex displayed 1.85 units mg1 of Arg-specific proteolytic activity but no Lys-specific proteolytic activity (Table 4
). The Kgp complex exhibited 0.66 units mg1 of Lys-specific proteolytic activity and no Arg-specific activity (Table 4
).
|
|
Immunogenicity of the wt complex
To characterize the immunogenicity of the Triton-wt complex and the sonication-wt complex, BALB/c mice were immunized (day 0 and day 30) with either sonication-wt complex or Triton-wt complex emulsified in incomplete IFA or with adjuvant alone. Twelve days after the second immunization, mice were challenged subcutaneously with P. gingivalis strain ATCC 33277. The development of lesions was monitored for the next 14 days for each group. Fig. 4
shows that the mean lesion size of mice immunized with purified Triton-wt complex or sonication-wt complex was significantly (P<0.01; P<0.05, respectively) smaller than that of the PBS/IFA control group. The Triton-wt complex, when used as a vaccine, tended to be more effective (d=1.85, 99 % CI: 3.07, 0.47) in providing protection as indicated by a larger effect size compared with the sonication-wt complex (d=1.32, 95 % CI: 2.28, 0.07). Moreover, only 50 % of the mice immunized with the Triton-wt complex developed P. gingivalis-induced lesions, whereas 70 % of the mice immunized with the sonication-wt complex developed lesions.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Using N-terminal sequence analysis and peptide mass fingerprinting, the extracted and purified Triton-wt complex was found to contain RgpAcat, RgpAA1, RgpAA2, RgpAA3, Kgpcat, KgpA1, KgpA2, HagAA2 and HagAA1*, corresponding to the molecular masses, as determined by SDS-PAGE and deduced from the gene sequence (Veith et al., 2002
) in parentheses of 45 (51), 44 (38), 17 (13), 15 (15), 48 (53), 39 (38), 17 (13), 17 (13) and 30 (28), respectively, which equates to the Triton-wt complex having a combined molecular mass of 272 (262) kDa, assuming stoichiometric amounts of each domain. This molecular mass is very similar to the relative molecular mass (260 kDa) of the smaller molecular mass peak of the Triton-wt complex determined by size-exclusion chromatography. However, the majority of the purified proteinaseadhesin complexes eluted in the void volume of the size-exclusion column, suggesting that the individual complexes may form larger aggregates on the cell surface as suggested by Takii et al. (2005)
or that the complexes further aggregate after they are released/extracted from the cell surface. Furthermore, for both the Kgp complex and RgpA complex, gel filtration peaks that correspond to the relative molecular masses of 120 kDa and 150 kDa, respectively, fitted well with the stoichiometric amounts of the domains identified for each complex; Kgpcat 48 (53), KgpA1 39 (38), KgpA2 17 (13) and HagA2 17 (13) producing 121 (117) kDa and RgpAcat 45 (51), RgpAA1 44 (38), RgpAA2 17 (13), RgpAA3 15 (15) and HagAA1* 30 (28) producing 151 (145) kDa, respectively.
The N-terminal sequence and cleavage sites of the protein domains from the Triton-Kgp complex and Triton-RgpA complex were compared with the corresponding domains of the Triton-wt complex. The N-terminal sequence and cleavage sites of Kgpcat, KgpA1 and KgpA2 from the P. gingivalis rgpA mutant and P. gingivalis W50 (wild-type) were identical, with an Arg residue preceding all the cleavage sites. This indicates that in the absence of RgpA proteinase activity, the N-terminal processing of Kgpcat, KgpA1 and KgpA2 domains of the Kgp complex is performed by another Arg-X proteinase, probably RgpB. Recently, Veith et al. (2002)
demonstrated that either RgpA or RgpB proteinase activity had a role in the N-terminal processing of Kgp proteins, where the N-termini of Kgpcat, KgpA1 and KgpA2 from an outer-membrane preparation of a rgpA/rgpB double mutant had extended and often ragged N-termini. Similarly, RgpAcat, RgpAA1 and RgpAA2 domains, but not the RgpAA3 adhesin domain, from the P. gingivalis kgp mutant and P. gingivalis W50 (wild-type) had identical N-termini with an Arg residue preceding the cleavage site, consistent with either RgpA and/or RgpB proteolytic activity being involved in the processing of these domains. The RgpAA3 adhesin domain from P. gingivalis W50 (wild-type) is preceded by a lysine residue, and the RgpAA3 adhesin of the RgpA complex extracted from the P. gingivalis kgp mutant was extended by six residues and was preceded by an arginine residue. This suggests that the Kgp proteinase normally participates in the proteolytic processing of the RgpAA3 domain in wild-type P. gingivalis and that in the absence of the Kgp proteinase, either RgpA or RgpB proteinase processes the RgpAA3 adhesin.
The processing of RgpA and Kgp polypeptides into fully active mature proteins on the cell surface is not yet fully understood. Recently, Mikolajczyk et al. (2003)
reported a possible activation pathway for RgpB, which involves the removal of N- and C-terminal extensions in three sequential autoproteolytic steps to generate fully active RgpB. Similarly, it has been suggested that prior to becoming fully processed and active proteins on the cell surface, the RgpA or Kgp polypeptides undergo a succession of proteolytic cleavages and these proteolytically processed domains become tightly associated and form the RgpA-Kgp proteinaseadhesin complex on the cell surface (Bhogal et al., 1997
). The N-terminal sequencing and PMF data shown in the present study demonstrate that the Kgp proteinase is involved in processing of the RgpAA3 adhesin domain and the majority of the RgpA and Kgp domains are processed by either the RgpA or RgpB proteinases. Using proteinase inhibitors to eliminate proteolytic processing during extraction, Veith et al. (2002)
showed that the RgpA and Kgp proteinase and adhesins are fully processed domains on the cell surface of P. gingivalis. Our data suggest that processed domains of the three polyproteins RgpA, Kgp and HagA combine non-covalently to form complexes either on the cell surface or immediately upon release from the cell surface.
It is interesting that in this study the C-terminal domains of both RgpA and Kgp were not found in the extracted complexes. RgpA-Kgp complexes characterized by Pike et al. (1994)
and Bhogal et al. (1997)
were reported to contain the C-terminal domain RgpAA4 as a 2730 kDa protein based on SDS-PAGE. Both Pike et al. (1994)
and Bhogal et al. (1997)
used N-terminal sequence analysis to identify RgpAA4. However, in the current study we used PMF analysis, which conclusively identified the protein domains in the 30 kDa band of the RgpA-Kgp complexes as KgpA1/HagAA1*. KgpA1 has an identical N-terminal sequence to RgpAA4, which would explain why Pike et al. (1994)
and Bhogal et al. (1997)
both assigned this band to RgpAA4. The pattern of protein bands obtained by SDS-PAGE analysis of the RgpA-Kgp complexes purified by Pike et al. (1994)
and Bhogal et al. (1997)
were the same as those obtained in this study with the Triton-wt complex, where PMF analysis confirmed the absence of the C-terminal domains of both RgpA and Kgp in the purified complex. Veith et al. (2002)
showed using 2D-PAGE analysis of P. gingivalis W50 outer membranes that the C-terminal domain of RgpA, RgpAA4 was present as a highly post-translationally modified form that reacted with mAb 1B5 whereas the other RgpA and Kgp domains obtained did not react with the mAb. This mAb has recently been reported to react with a phosphorylated branched mannan that has been suggested to be part of the outermost layer of the P. gingivalis cell wall (Paramonov et al., 2005
). These results together suggest that the C-terminal domain of RgpAA4 may be attached to the cell wall and hence may serve to anchor the complex to the cell. Treatment of the cell with Triton X-114 may have dissociated the RgpA-Kgp complex from its C-terminal anchor or may have triggered proteolytic processing, releasing the complex from the attached C-terminal domain.
As RgpA and Kgp are reported to be major virulence factors of P. gingivalis (reviewed by O'Brien-Simpson et al., 2004
), we evaluated the protective efficacy of the complexes as vaccines in the murine lesion model. Both the Triton-wt complex and sonication-wt complex provided protection against challenge with P. gingivalis. However, the Triton-wt complex, when used as a vaccine, tended to be more effective in providing protection (as indicated by a larger effect size) compared with the sonication-wt complex. Moreover, immunization with Triton-wt complex induced higher levels of IgG, IgG1, IgG2a, IgG2b and IgG3 antibodies compared with the sonication-wt complex. The predominant antibody subclass induced was IgG1 (equivalent to IgG4 in humans), which is a Th2 cytokine-induced antibody that has previously been shown to be involved in a protective immune response against P. gingivalis-induced lesions in the mouse (O'Brien-Simpson et al., 2000
). Furthermore, Western blot analysis suggested that antibodies to the Triton-wt complex bound strongly to RgpAA1, KgpA1 and HagAA1* adhesins, whereas antibodies to the sonication-wt complex bound to RgpAA1 and KgpA1. These data suggest that the complex extracted using the Triton X-114 method produces a strong antibody response directed towards the A1 adhesins of RgpA, Kgp and HagA. The RgpAA1, KgpA1 and HagAA1* adhesins share a high degree of sequence similarity and interestingly, each contain the previously described protective peptide epitopes ABM1, ABM2 and ABM3 (O'Brien-Simpson et al., 2000
). Taken together, our results suggest that proteinaseadhesin complexes extracted from P. gingivalis are composed of processed domains of all three polyproteins, RgpA, Kgp and HagA, and that the superiority of the Triton X-114-extracted complex in protection may relate to the Triton complex more closely resembling the form of the proteins on the cell surface.
Binding studies demonstrated that the Triton-wt complex, sonication-wt complex, RgpA complex and Kgp complex bind at nanomolar levels to fibrinogen, fibronectin, collagen type V and haemoglobin. Interestingly, the Triton-wt complex demonstrated a higher affinity to all the proteins tested compared with the sonication-wt complex. The RgpA complex exhibited higher binding for all the proteins tested compared with the Kgp complex with the exception of binding to haemoglobin, where the KD for each complex was similar. In an earlier study, Pike et al. (1996)
reported that the RgpA complex and Kgp complex purified from the culture supernatant of P. gingivalis strain HG66 bound to fibrinogen, fibronectin and laminin. The KD of binding to fibrinogen was reported to be 8.5 nM and 4.0 nM for the RgpA complex and Kgp complex, respectively. This KD of binding to fibrinogen is in good agreement with our findings, where the KD of the Kgp complex binding to fibrinogen was 4.9±0.2 nM. However, in the present study the RgpA complex had a stronger binding to fibrinogen, with a KD of 2.07±0.11 nM. This could be due to differences in strain, age of culture and purification method used between the two studies. Knibbs et al. (1998)
reported that the affinity of a protein to its ligand can be enhanced with an increase in ligand valency. Therefore, the higher binding to host proteins of the Triton-wt complex and RgpA complex compared with the Kgp complex may be due to the valency of ABMs in each complex. O'Brien-Simpson et al. (2005)
have shown that antibodies directed to ABM2 (SYTYTVYRDGTKIKEGLTATTFEEDGVAA) block binding of the complex to fibrinogen, fibronectin and collagen type V, and antibodies to ABM3 (VTLKWDAPNGTPNPNPNPNPNPNPGTTTLSESF) block binding to haemoglobin. ABM2 is repeated three times in the adhesin domains of the RgpA complex and twice in the adhesin domains of Kgp complex, whereas ABM3 is repeated only once in the RgpA complex and Kgp complex. Thus, the stronger binding of the RgpA complex to fibrinogen, fibronectin and collagen type V may be due to the presence of a greater number of ABM2 sequences in its adhesin domains. In contrast, the similar levels of binding to haemoglobin observed with both the RgpA and Kgp complex may be explained by the presence of the same number of ABM3 sequences in their adhesin domains. The Triton-wt complex, which has the highest valency of ABM2 and ABM3 sequences, was found to have the strongest levels of binding to all the proteins tested. However, the higher affinity of the Triton-wt complex for host proteins may also relate to the unique conformation formed upon complex formation. This ability to bind to a variety of extracellular matrix (ECM) proteins may play an important role in P. gingivalis virulence as adherence to ECM proteins has been reported to be a crucial step in the pathogenic process associated with many bacteria (Schwarz-Linek et al., 2004
). Similar to other microbial surface proteins that bind ECM proteins, the RgpA-Kgp complex can also be considered to be part of the family of cell-surface adhesin molecules called MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) (Patti et al., 1994
; Schwarz-Linek et al., 2004
). The adherence of the proteinaseadhesin complexes to collagen type V may be an important factor in the reported links between periodontitis and cardiovascular diseases and preterm birth of infants (Beck et al., 1998
; Offenbacher et al., 1998
; Spahr et al., 2006
). Collagen type V is located in the basement membrane of human aortas, arteries and atherosclerotic plaques. It is also found in the endothelial basement membranes of the placenta and in the amniotic basement membrane (Merker et al., 1987
; Polzin et al., 1997
). The relative concentration of collagen type V has been reported to increase during the development and ageing of the placenta (Iwahashi et al., 1996
).
In conclusion, we have developed a simple and efficient method for the extraction and purification of the complexes of the processed domains of RgpA, Kgp and HagA from P. gingivalis using Triton X-114 and Arg-affinity chromatography. The Triton-extracted complexes bound at high affinity to a range of host proteins and when used as an immunogen provided protection against challenge with P. gingivalis in a murine model of infection.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Beck, J. D., Offenbacher, S., Williams, R., Gibbs, P. & Garcia, R. (1998). Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 3, 127141.[Medline]
Bedi, G. S. & Williams, T. (1994). Purification and characterization of a collagen-degrading protease from Porphyromonas gingivalis. J Biol Chem 269, 599606.
Bhogal, P. S., Slakeski, N. & Reynolds, E. C. (1997). A cell-associated protein complex of Porphyromonas gingivalis W50 composed of Arg- and Lys-specific cysteine proteinases and adhesins. Microbiology 143, 24852495.[Abstract]
Bordier, C. (1981). Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256, 16041607.
Brooks, C. S., Vuppala, S. R., Jett, A. M. & Akins, D. R. (2006). Identification of Borrelia burgdorferi outer surface proteins. Infect Immun 74, 296304.
Brown, L. J., Johns, B. A. & Wall, T. P. (2000). The economics of periodontal diseases. Periodontology 29, 223234.[CrossRef]
Chen, Z., Potempa, J., Polanowski, A., Wikstrom, M. & Travis, J. (1992). Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem 267, 1889618901.
Cohen, J. (1969). Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press.
Cullen, P. A., Cordwell, S. J., Bulach, D. M., Haake, D. A. & Adler, B. (2002). Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun 70, 23112318.
Curtis, M. A., Kuramitsu, H. K., Lantz, M., Macrina, F. L., Nakayama, K., Potempa, J., Reynolds, E. C. & Aduse-Opoku, J. (1999). Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J Periodontal Res 34, 464472.[CrossRef][Medline]
Evans, R. T., Klausen, B., Ramamurthy, N. S., Golub, L. M., Sfintescu, C. & Genco, R. J. (1992). Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch Oral Biol 37, 813819.[CrossRef][Medline]
Fujimura, S., Hirai, K., Shibata, Y., Nakayama, K. & Nakamura, T. (1998). Comparative properties of envelope-associated arginine-gingipains and lysine-gingipain of Porphyromonas gingivalis. FEMS Microbiol Lett 163, 173179.[CrossRef][Medline]
Iwahashi, M., Ooshima, A. & Nakano, R. (1996). Increase in the relative level of type V collagen during development and ageing of the placenta. J Clin Pathol 49, 916919.
Jain, A., Batista, E. L., Jr, Serhan, C., Stahl, G. L. & Van Dyke, T. E. (2003). Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 71, 60126018.
Knibbs, R. N., Takagaki, M., Blake, D. A. & Goldstein, I. J. (1998). The role of valence on the high-affinity binding of Griffonia simplicifolia isolectins to type A human erythrocytes. Biochemistry 37, 1695216957.[CrossRef][Medline]
Kontani, M., Ono, H., Shibata, H., Okamura, Y., Tanaka, T., Fujiwara, T., Kimura, S. & Hamada, S. (1996). Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins. Infect Immun 64, 756762.[Abstract]
Lamont, R. J. & Jenkinson, H. F. (2000). Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol 15, 341349.[CrossRef][Medline]
Lin, D., Smith, M. A., Champagne, C., Elter, J., Beck, J. & Offenbacher, S. (2003). Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice. Infect Immun 71, 51565162.
Mercado, F. B., Marshall, R. I., Klestov, A. C. & Bartold, P. M. (2001). Relationship between rheumatoid arthritis and periodontitis. J Periodontol 72, 779787.[CrossRef][Medline]
Merker, H. J., Bremer, D., Barrach, H. J. & Gossrau, R. (1987). The basement membrane of the persisting maternal blood vessels in the placenta of Callithrix jacchus. Anat Embryol 176, 8797.[CrossRef][Medline]
Mikolajczyk, J., Boatright, K. M., Stennicke, H. R., Nazif, T., Potempa, J., Bogyo, M. & Salvesen, G. S. (2003). Sequential autolytic processing activates the zymogen of Arg-gingipain. J Biol Chem 278, 1045810464.
Miyakawa, H., Honma, K., Qi, M. & Kuramitsu, H. K. (2004). Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis. J Periodontal Res 39, 19.[CrossRef][Medline]
Mortz, E., Vorm, O., Mann, M. & Roepstorff, P. (1994). Identification of proteins in polyacrylamide gels by mass spectrometric peptide mapping combined with database search. Biol Mass Spectrom 23, 249261.[CrossRef][Medline]
O'Brien-Simpson, N. M., Paolini, R. A. & Reynolds, E. C. (2000). RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a muri